{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:22:11Z","timestamp":1790673731855,"version":"4.1.0"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T00:00:00Z","timestamp":1635206400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["SAF2017-83674-C2-1-R"],"award-info":[{"award-number":["SAF2017-83674-C2-1-R"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["SAF2017-83674-C2-2-R"],"award-info":[{"award-number":["SAF2017-83674-C2-2-R"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016386","name":"Conselleria de Innovaci\u00f3n, Universidades, Ciencia y Sociedad Digital, Generalitat Valenciana","doi-asserted-by":"publisher","award":["ACIF\/2019\/054"],"award-info":[{"award-number":["ACIF\/2019\/054"]}],"id":[{"id":"10.13039\/501100016386","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016386","name":"Conselleria de Innovaci\u00f3n, Universidades, Ciencia y Sociedad Digital, Generalitat Valenciana","doi-asserted-by":"publisher","award":["PROMETEO\/2018\/114"],"award-info":[{"award-number":["PROMETEO\/2018\/114"]}],"id":[{"id":"10.13039\/501100016386","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Ministerio de Ciencia, Innovaci\u00f3n y Universidades","doi-asserted-by":"publisher","award":["FPU16\/00283"],"award-info":[{"award-number":["FPU16\/00283"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["SAF2017-83674-C2-2-R"],"award-info":[{"award-number":["SAF2017-83674-C2-2-R"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Perfluorohexyloctane (F6H8) eyedrops have been recently introduced in Europe as a product to treat dry eye disease, based on its ability to reduce tear film instability in Meibomian gland dysfunction and evaporative dry eye disease, although its mechanism of action is still unknown. In the present pilot study, we evaluated the effects of the ocular instillation of a single drop of commercial F6H8 eyedrops in 20 healthy humans (9 women\/11 men), measuring: (a) Corneal surface temperature (CST) from infrared video images; (b) tear volume using phenol red threads; (c) blinking frequency; and (d) ocular surface sensations (cold, dryness, pricking, foreign body, burning, itching, gritty, eye fatigue, watering eyes, and light-evoked discomfort sensations; scored using 10 cm Visual Analog Scales), before and 5\u201360 min after F6H8 or saline treatment. CST decreased and tearing and blinking frequency increased significantly after F6H8 but not after saline solution. When applied unilaterally, CST decreased only in the F6H8-treated eye. No sensations were evoked after F6H8 or saline. The corneal surface temperature reduction produced by topical F6H8 does not evoke conscious ocular sensations but is sufficient to increase the activity of corneal cold thermoreceptors, leading to an increased reflex lacrimation and blinking that may relieve dry eye condition thus reducing ocular discomfort and pain.<\/jats:p>","DOI":"10.3389\/fmed.2021.709712","type":"journal-article","created":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T04:52:16Z","timestamp":1635223936000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":22,"title":["Deciphering the Action of Perfluorohexyloctane Eye Drops to Reduce Ocular Discomfort and Pain"],"prefix":"10.3389","volume":"8","author":[{"given":"Miguel","family":"Delicado-Miralles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Velasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariadna","family":"D\u00edaz-Tahoces","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juana","family":"Gallar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Carmen","family":"Acosta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adolfo","family":"Aracil-Marco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,10,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1016\/j.ophtha.2017.07.010","article-title":"The pathophysiology of dry eye disease: what we know and future directions for research","volume":"124","author":"Pflugfelder","year":"2017","journal-title":"Ophthalmology."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e241","DOI":"10.1097\/OPX.0000000000000567","article-title":"How blink anomalies can contribute to post-LASIK neurotrophic epitheliopathy","volume":"92","author":"McMonnies","year":"2015","journal-title":"Optom Vis Sci."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1038\/nm.2264","article-title":"Ocular surface wetness is regulated by TRPM8-dependent cold thermoreceptors of the cornea","volume":"16","author":"Parra","year":"2010","journal-title":"Nat Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"7150","DOI":"10.1038\/ncomms8150","article-title":"TRPM8 is a neuronal osmosensor that regulates eye blinking in mice","volume":"6","author":"Quallo","year":"2015","journal-title":"Nat Commun."},{"key":"B5","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3238\/arztebl.2015.0071","article-title":"The pathophysiology, diagnosis, and treatment of dry eye disease","volume":"112","author":"Messmer","year":"2015","journal-title":"Dtsch Aerzteblatt Online"},{"key":"B6","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","article-title":"TFOS DEWS II definition and classification report","volume":"15","author":"Craig","year":"2017","journal-title":"Ocul Surf."},{"key":"B7","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jtos.2013.02.002","article-title":"Dry eye disease treatment: a systematic review of published trials and a critical appraisal of therapeutic strategies","volume":"11","author":"Alves","year":"2013","journal-title":"Ocul Surf."},{"key":"B8","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1089\/jop.2015.0048","article-title":"Semifluorinated alkane eye drops for treatment of dry eye disease\u2013a prospective, multicenter noninterventional study","volume":"31","author":"Steven","year":"2015","journal-title":"J Ocul Pharmacol Ther."},{"key":"B9","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1023\/A:1006444615412","article-title":"Perfluorohexyloctane as a long-term vitreous tamponade in the experimental animal. Experimental perfluorohexyloctane substitution","volume":"23","author":"Zeana","year":"1999","journal-title":"Int Ophthalmol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1177\/112067210001000301","article-title":"Semifluorinated alkanes\u2013a new class of compounds with outstanding properties for use in ophthalmology","volume":"10","author":"Meinert","year":"2000","journal-title":"Eur J Ophthalmol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1089\/jop.2017.0042","article-title":"Semifluorinated alkane eye drops for treatment of dry eye disease due to meibomian gland disease","volume":"33","author":"Steven","year":"2017","journal-title":"J Ocul Pharmacol Ther."},{"key":"B12","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.jtos.2019.02.010","article-title":"Preclinical studies evaluating the effect of semifluorinated alkanes on ocular surface and tear fluid dynamics","volume":"17","author":"Agarwal","year":"2019","journal-title":"Ocul Surf"},{"key":"B13","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1089\/jop.2019.0092","article-title":"Influence of perfluorohexyloctane eye drops on tear film thickness in patients with mild to moderate dry eye disease: a randomized controlled clinical trial","volume":"36","author":"Schmidl","year":"2020","journal-title":"J Ocul Pharmacol Ther."},{"key":"B14","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.oftale.2020.05.015","article-title":"Effects and safety of perfluorohexyloctane on the eye surface and corneal endothelium","volume":"95","author":"Mateo Orobia","year":"2020","journal-title":"Arch Soc Espa\u00f1ola Oftalmol."},{"key":"B15","first-page":"465","article-title":"Infrared thermography of the ocular surface of tear-deficient eyes treated with perfluorohexyloctane","volume":"58","author":"Acosta","year":"2017","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"B16","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/S2173-5794(10)70015-3","article-title":"Analysis of incidence of ocular surface disease index with objective tests and treatment for dry eye","volume":"85","author":"Rodr\u00edguez-Torres","year":"2010","journal-title":"Arch Soc Espa\u00f1ola Oftalmol"},{"key":"B17","first-page":"2063","article-title":"Sensations evoked by selective mechanical, chemical, and thermal stimulation of the conjunctiva and cornea","volume":"42","author":"Acosta","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B18","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S0002-9394(01)01365-4","article-title":"Impaired functional visual acuity of dry eye patients","volume":"133","author":"Goto","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3758\/BF03193146","article-title":"G*Power 3: a flexible statistical power analysis program for the social, behavioral, biomedical sciences","volume":"39","author":"Faul","year":"2007","journal-title":"Behav Res Meth."},{"key":"B20","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/ICL.0000000000000680","article-title":"A review on evidence-based treatments for meibomian gland dysfunction","volume":"46","author":"Lam","year":"2020","journal-title":"Eye Contact Lens."},{"key":"B21","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.clae.2017.12.003","article-title":"Tear evaporation rates: what does the literature tell us?","volume":"41","author":"Wong","year":"2018","journal-title":"Contact Lens Anterior Eye."},{"key":"B22","doi-asserted-by":"publisher","first-page":"3054","DOI":"10.1021\/la00060a025","article-title":"Surface activity of semifluorinated alkanes: F(CF2)m(CH2)nH","volume":"7","author":"Gaines","year":"1991","journal-title":"Langmuir."},{"key":"B23","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.cis.2007.11.002","article-title":"Semifluorinated alkanes - primitive surfactants of fascinating properties","volume":"138","author":"Broniatowski","year":"2008","journal-title":"Adv Colloid Interface Sci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"110564","DOI":"10.1016\/j.colsurfb.2019.110564","article-title":"Perfluorohexyloctane (F6H8) as a delivery agent for cyclosporine A in dry eye syndrome therapy \u2013 langmuir monolayer study complemented with infrared nanospectroscopy","volume":"184","author":"Chachaj-Brekiesz","year":"2019","journal-title":"Colloids Surfaces B Biointerfaces."},{"key":"B25","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1111\/j.1469-7793.2001.t01-1-00511.x","article-title":"Sensory experiences in humans and single-unit activity in cats evoked by polymodal stimulation of the cornea","volume":"534","author":"Acosta","year":"2001","journal-title":"J Physiol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1167\/iovs.03-1366","article-title":"Tear secretion induced by selective stimulation of corneal and conjunctival sensory nerve fibers","volume":"45","author":"Acosta","year":"2004","journal-title":"Invest Ophthalmol Vis Sci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ijpharm.2018.01.019","article-title":"Semifluorinated alkane based systems for enhanced corneal penetration of poorly soluble drugs","volume":"538","author":"Agarwal","year":"2018","journal-title":"Int J Pharm"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1136\/bjo.2008.156828","article-title":"Turnover rate of tear-film lipid layer determined by fluorophotometry","volume":"93","author":"Mochizuki","year":"2009","journal-title":"Br J Ophthalmol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s00417-006-0414-3","article-title":"Effect of gravity in long-term vitreous tamponade: In vivo investigation using perfluorocarbon liquids and semi-fluorinated alkanes","volume":"245","author":"Mackiewicz","year":"2007","journal-title":"Graefe Arch Clin Exp Ophthalmol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.ejpb.2019.06.008","article-title":"Topical semifluorinated alkane-based azithromycin suspension for the management of ocular infections","volume":"142","author":"Agarwal","year":"","journal-title":"Eur J Pharm Biopharm"},{"key":"B31","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1136\/bjo.52.10.729","article-title":"Determinants of corneal temperature","volume":"52","author":"Mapstone","year":"1968","journal-title":"Br J Ophthalmol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.jtos.2017.05.002","article-title":"TFOS DEWS II pain and sensation report","volume":"15","author":"Belmonte","year":"2017","journal-title":"Ocul Surf."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1016\/j.pain.2014.04.025","article-title":"Tear fluid hyperosmolality increases nerve impulse activity of cold thermoreceptor endings of the cornea","volume":"155","author":"Parra","year":"2014","journal-title":"Pain."},{"key":"B34","first-page":"148","article-title":"Ocular surface temperature in sj\u00f6gren's syndrome","volume":"59","author":"Merino","year":"2018","journal-title":"Investig Opthalmology Vis Sci."},{"key":"B35","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s40135-015-0073-9","article-title":"What causes eye pain?","volume":"3","author":"Belmonte","year":"2015","journal-title":"Curr Ophthalmol Rep."},{"key":"B36","doi-asserted-by":"publisher","first-page":"3671","DOI":"10.1167\/iovs.08-2689","article-title":"A link between tear instability and hyperosmolarity in dry eye","volume":"50","author":"Liu","year":"2009","journal-title":"Investig Ophthalmol Vis Sci."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.709712\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T04:52:23Z","timestamp":1635223943000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.709712\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,26]]},"references-count":36,"alternative-id":["10.3389\/fmed.2021.709712"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2021.709712","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,26]]},"article-number":"709712"}}